Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Purple Biotech (PPBT) Debt Ratio (2017 - 2020)

Purple Biotech has reported Debt Ratio over the past 4 years, most recently at 0.28 for Q2 2020.

  • Quarterly Debt Ratio rose 99.53% to 0.28 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was 0.28 through Jun 2020, up 99.53% year-over-year, with the annual reading at 0.04 for FY2018, 73.48% down from the prior year.
  • Debt Ratio was 0.28 for Q2 2020 at Purple Biotech, up from 0.14 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.28 in Q2 2020 and troughed at 0.04 in Q4 2018.
  • The 4-year median for Debt Ratio is 0.14 (2017), against an average of 0.15.
  • The largest YoY upside for Debt Ratio was 254.49% in 2018 against a maximum downside of 73.48% in 2018.
  • A 4-year view of Debt Ratio shows it stood at 0.14 in 2017, then plummeted by 73.48% to 0.04 in 2018, then surged by 278.9% to 0.14 in 2019, then skyrocketed by 99.53% to 0.28 in 2020.
  • Per Business Quant, the three most recent readings for PPBT's Debt Ratio are 0.28 (Q2 2020), 0.14 (Q2 2019), and 0.04 (Q4 2018).